Joslin researchers gain new understanding of diabetes and kidney disease

Findings may lead to effective new treatments

2012-07-24

(Press-News.org) BOSTON – July 23, 2012 – Scientists at Joslin Diabetes Center have identified biological mechanisms by which glucagon-like peptide-1 (GLP-1), a gut hormone, protects against kidney disease, and also mechanisms that inhibit its actions in diabetes. The findings, which are reported today online by Diabetes, may lead to the development of new therapeutic agents that harness the actions of GLP-1 to prevent the harmful effects of hyperglycemia on renal endothelial cells.

Renal complications, also known as diabetic nephropathy, are one of the most life-threatening complications of diabetes that often lead over time to end-stage renal disease (ESRD). About a half million people in the US – 44 percent of whom are diabetics -- have ESRD, which requires dialysis or kidney transplantation. As a result, investigating the relationship of diabetes to renal dysfunction is a major focus of diabetes research. "We are very eager to develop new treatments for diabetic kidney disease," says George King, M.D., lead author of the study, and chief scientific officer, head of the Dianne Nunnally Hoppes Laboratory for Diabetes Complications and a professor of medicine at Harvard Medical School.

GLP-1 is an incretin hormone that is produced by the intestine in response to food. GLP-1 increases the secretion of insulin from the pancreas, slows absorption of glucose from the gut, and reduces the action of glucagon – all of which lower glucose levels in the blood. In addition, GLP-1 reduces appetite. The drug, exendin-4 (marketed as Exenatide), which mimics the effects of GLP-1, is used to lower blood glucose in type 2 diabetes.

Recent studies have reported that GLP-1 improves the function of renal endothelial cells (which regulate blood clotting, immune response and blood vessel activity, among other critical functions, and are impaired by insulin resistance) and can prevent some renal pathologies in diabetic rodents. GLP-1 receptors (GLP-1R), which are abundant in the intestine, are also found in the endothelium and kidney.

The Joslin study investigated the effects of GLP-1 in non-diabetic and diabetic mice with an "overexpression" of the enzyme PKCβ (protein kinase C-beta) which is produced in excess when blood glucose is high. Excess PKCβ can lead to diabetes complications, including kidney disease. PKCβ enhances the action of angiotensin II (Ang II), a peptide hormone that affects renal filtration and blood flow and also regulates blood pressure, which increases inflammation and accelerates the progression of kidney damage.

The study looked at the interactions of GLP-1, PKC-beta and ANG II that affect GLP-1's protective action in renal endothelial cells. "We've been interested in diabetic kidney disease for a long time, particularly the role of PKCβ and Ang II in promoting kidney damage," says Dr. King. "We were interested in investigating how GLP-1 could protect against the effects of hyperglycemia on renal function."

Josin researchers made two major findings: They identified the mechanisms by which GLP-1 can induce protective actions on the glomerular (renal) endothelial cells by inhibiting the signaling pathway of Ang II and its pro-inflammatory effect; and demonstrated a dual signaling mechanism by which hyperglycemia, via PKCβ activation, can increase Ang II action and inhibit GLP-1's protective effects by reducing the expression of GLP-1 receptors in the glomerular endothelial cells. "We know that people with diabetes are more sensitive to Ang II; our data suggests one reason why," says Dr. King.

The results suggest that effective therapeutic agents could be developed to enhance the effects of GLP-1R on the endothelium which may prevent glomerular endothelial dysfunction and slow the progression of diabetic nephropathy. "We now know that increased PKCβ decreases GLP-1R which makes the kidney less responsive to treatment with GLP-1-based drugs. Possible new treatments could combine PKCβ inhibitors with higher doses of GLP-1 agonists. GLP-1 is one potential pharmaceutical that could both lower glucose and minimize the toxic effects of Ang II to lower the risk of kidney diseases," says Dr. King.

INFORMATION:

The study was funded by the National Eye Institute (NEI), a component of the National Institutes of Health.

About Joslin Diabetes Center

Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes research and clinical care organization. Joslin is dedicated to ensuring that people with diabetes live long, healthy lives and offers real hope and progress toward diabetes prevention and a cure. Joslin is an independent, nonprofit institution affiliated with Harvard Medical School.

Our mission is to prevent, treat and cure diabetes. Our vision is a world free of diabetes and its complications.

For more information , visit www.joslin.org.

Keep up with Joslin research and clinical news at Inside Joslin at www.joslin.org/news/inside_joslin.html,

ELSE PRESS RELEASES FROM THIS DATE:

ICAP study finds concerningly high HIV infection rates for young black gay and bisexual men in US

2012-07-24

Researchers at ICAP's Harlem Prevention Center (HPC) joined the HIV Prevention Trials Network (HPTN) today to announce study results that showed disturbing rates of new HIV infections occurring among black gay and bisexual men in the U.S. (also known as men who have sex with men, or MSM), particularly young black MSM. The HPTN 061 study showed that the overall rate of new HIV infection among black MSM in this study was 2.8% per year, a rate that is nearly 50% higher than in white MSM in the U.S. Even more alarming, HPTN 061 found that young black MSM—those 30 years of ...

UCSB researchers achieve world's first violet nonpolar vertical-cavity laser technology

2012-07-24

In a leap forward for laser technology, a team at University of California, Santa Barbara, has developed the first violet nonpolar vertical-cavity surface-emitting lasers (VCSELs) based on m-plane gallium nitride semiconductors. This recent discovery by LED pioneer Shuji Nakamura and his research team at UCSB is an achievement in VCSEL technology that opens doors for higher optical efficiency lasers at greatly reduced manufacturing costs for a variety of applications. "We have demonstrated working, electrically-injected nonpolar m-plane nitride VCSELs lasing at room ...

Making allowances for job seekers on Facebook

2012-07-24

Your inappropriate Facebook profile, posts and photos could lose you your next job, according to an in-depth study of employers from six different industries. The conclusion of a paper to be published in the International Journal of Work Innovation this month reveals that many employers are using the Facebook profiles of job candidates to filter out weaker applicants based on perception of lifestyle, attitudes and personal appearance. Vanessa A. de la Llama, Isabel Trueba, Carola Voges, Claudia Barreto and David J. Park of the School of Journalism and Mass Communication, ...

Fools' gold found to regulate oxygen

2012-07-24

As sulfur cycles through Earth's atmosphere, oceans and land, it undergoes chemical changes that are often coupled to changes in other such elements as carbon and oxygen. Although this affects the concentration of free oxygen, sulfur has traditionally been portrayed as a secondary factor in regulating atmospheric oxygen, with most of the heavy lifting done by carbon. However, new findings that appeared this week in Science suggest that sulfur's role may have been underestimated. Drs. Itay Halevy of the Weizmann Institute's Environmental Science and Energy Research Department ...

Judging DNA by its cover

2012-07-24

Stem cells hold great promise for the medicine of the future, but they can also be a cause of disease. When these self-renewing, unspecialized cells fail to differentiate into diverse cell types, they can start dividing uncontrollably, leading to cancer. Already several decades ago, Weizmann Institute scientists were among the first to demonstrate the link between cancer and the faulty differentiation of stem cells. Now a new Weizmann Institute-led study, published in Molecular Cell, reveals a potential molecular mechanism behind this link. The scientists managed to ...

32-country study shows that type 2 diabetes drug is clinically effective for long-term use

2012-07-24

An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination with other selected oral anti-diabetic medication. The 32-country study, published in the August issue of IJCP, the International Journal of Clinical Practice, followed 2,121 individuals who had taken part in four previous 24-week randomised, double-blind, placebo controlled trials, in order to monitor them for a further 78 weeks. Those ...

Caught in the act: Bats use the sound of copulating flies as a cue for foraging

2012-07-24

Mating at night does not necessarily lead to offspring, at least in flies: males produce a buzzing sound with their wings that can be perceived by bats. Stefan Greif from the Max Planck Institute for Ornithology, and colleagues, observed this in a long-term study on wild Natterer's bats that eat the copulating flies in a double-sized meal. Flies that were just sitting or walking on the ceiling did not elicit a predatory response by the bats. This is the first experimental evidence how mating itself can be risky. Mating activities are a dangerous business because the attention ...

Snacking and BMI linked to double effect of brain activity and self-control

2012-07-24

Snack consumption and BMI are linked to both brain activity and self-control, new research has found. The research, carried out by academics from the Universities of Exeter, Cardiff, Bristol, and Bangor, discovered that an individual's brain 'reward centre' response to pictures of food predicted how much they subsequently ate. This had a greater effect on the amount they ate than their conscious feelings of hunger or how much they wanted the food, A strong brain response was also associated with increased weight (BMI), but only in individuals reporting low levels of ...

Public sightings suggest increase in basking sharks in British waters

2012-07-24

The number of basking sharks recorded in Britain's seas could be increasing, decades after being protected from commercial hunting in the late 20th century. The most comprehensive analysis ever undertaken of basking shark sightings in UK waters, by the University of Exeter, the Marine Conservation Society (MCS), Cornwall Wildlife Trust (CWT) and Wave Action, is published in the journal Marine Ecology Progress Series. The northeast Atlantic hosted an extensive commercial fishery for basking sharks, mainly in Norway, Ireland and Scotland, where more than 81,000 were killed ...

New line of approach for combination therapy against melanoma

2012-07-24

A melanoma is a malignant form of skin cancer and is one of the most aggressive types of tumors there is. Treatment is particularly difficult, because melanomas are usually resistant against conventional chemotherapy treatments. Agnieszka Gembarska and Chris Marine (VIB/KU Leuven) have found a new line of approach in which to treat these aggressive skin cancers, namely by combating the interaction between the protein MDM4 and the tumor suppressor p53. Their research offers a new angle for the development of medication and confirms that combination therapies – including ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Joslin researchers gain new understanding of diabetes and kidney disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: